http://web.archive.org/web/20150719044248id_/http://www.dailymail.co.uk/health/article-2961947/The-new-gel-boosts-woman-s-sex-life-menopause.html

a new once - daily hormone treatment has boosted the sex lives of older women			1
using vagicap increased by a third the number of women getting sexual satisfaction , say findings from a trial			1
the treatment , which is not yet available , is aimed at women who experience pain during sex and other symptoms caused by the menopause			2
more than half of post-menopausal women suffer vaginal dryness that can make sex uncomfortable because of a lack of the hormone oestrogen			1
a new gel claims to be able to boost a woman 's sex life after the menopause - by relieving the pain and discomfort associated with a lack of oestrogen the new treatment is a tear - shaped softgel capsule designed for easy insertion once a day , alleviating local symptoms			1
however , the oestrogen has less effect throughout the body than hormone replacement therapy ( @entity36 ) which should lessen any side effects			0
dr @entity38 , chief of the @entity39 at @entity40 in @entity41 , presented the trial at the @entity43 of women 's @entity44 , in @entity45 , @entity46			0
dr @entity38 said : ‘ menopause is typically associated with hot flashes ( flushes ) , but there are other common and distressing symptoms such as pain and discomfort during sex due to lack of oestrogen			0
‘ approximately 30 million women in the @entity58 experience this condition , which can really impact their quality of life			0
’ she said the @entity64 , if approved by regulatory authorities , could be a treatment that women ‘ may find to be convenient and easy to use ’			2
at least half of menopausal women experience uncomfortable , often distressing symptoms such as dryness - making sex painful in the @entity72 , the average age of the menopause is 51 years , when periods stop and oestrogen hormone levels decline			1
research earlier this week found at least half of menopausal women experienced uncomfortable , often distressing symptoms for more than seven years on average and often much longer			0
the latest study involved women between the ages of 40 - 75 who were assigned to use the @entity64 once daily – usually at the same time in the morning – or a placebo ( dummy ) treatment			1
a qualitative survey by the researchers found that 63 per cent of women on the @entity64 reported an improvement in quality of life after only two weeks of therapy treatment , compared to 48 per cent on the placebo			2
dr @entity38 said : ‘ for many women , symptoms such as these have a major impact on frequency and spontaneity of their sexual activity			0
‘ it is essential that health care attendants routinely engage in open and sensitive discussions with postmenopausal women to ensure that symptomatic atrophy is detected early and appropriately managed			1
’ new treatment options have the potential to improve satisfaction for these women , she said			0
‘ there is medical consensus that oestrogen administered locally is the preferred mode of treatment for both symptom reduction and restoring and maintaining healthy vaginal tissue and sexual function ’ she added			0
@entity119 , manufacturers of the @entity64 , began a phase three trial in september 2014 which is investigating 4 mcg , 10 mcg and 25 mcg doses of oestrogen as different options to meet women 's treatment needs .			2

@entity64 is a tear - shaped capsule designed to be inserted into the vagina
it raised the number of women getting sexual satisfaction by a third
over half of postmenopausal women suffer dryness - making sex painful

@entity36:HRT
@entity39:Division of Behavioral Medicine Department
@entity38:Kingsberg
@entity44:Sexual Health Annual Meeting
@entity45:Austin
@entity46:Texas
@entity40:UH Case Medical Center
@entity41:Cleveland
@entity43:International Society
@entity64:VagiCap
@entity58:United States
@entity119:TherapeuticsM
@entity72:UK